Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis

摘要

BackgroundA 100% apheresis platelet supply is considered to increase transfusion safety by lowering donor exposures for transfusion recipients. We performed a risk benefit analysis to contrast the reduction of donor exposures and the risk of contaminated blood products in the nation-wide inventory with the donor risks associated with a switch to a 100% apheresis platelet supply in Germany.